Craft

Beyond Air

Stock Price

$0.5

2024-10-29

Market Capitalization

$34.1 M

2024-10-29

Revenue

$1.2 M

FY, 2024

Beyond Air Summary

Company Summary

Overview
Beyond Air is a clinical-stage medical device and biopharmaceutical company using nitric oxide to treat respiratory and other diseases. It develops the LungFit system that uses proprietary technology to generate nitric oxide from ambient air and help patients with respiratory conditions and severe lung infections.
Type
Public
Status
Active
Founded
2011
HQ
Uniondale, NY, US | view all locations
Website
https://www.beyondair.net
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Steve Lisi

    Steve Lisi, CEO and Chairman of the Board

    • Ron Bentsur, Director

      • Erick Lucera, Director

        • Frederick Montgomery

          Frederick Montgomery, Vice President of Medical Systems

          LocationsView all

          2 locations detected

          • Uniondale, NY HQ

            United States

            825 E Gate Blvd #320

          • Rehovot, Center District

            Israel

            Eli Horovitz St 12

          Beyond Air Financials

          Summary Financials

          Revenue (Q3, 2025)
          $1.1M
          Gross profit (Q3, 2025)
          ($215.0K)
          Net income (Q3, 2025)
          ($13.3M)
          Cash (Q3, 2025)
          $4.6M
          EBIT (Q3, 2025)
          ($11.0M)
          Enterprise value
          $41.4M

          Footer menu